Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hutchison MediPharma Founder And CEO Samantha Du On China's Drug R&D Ecosystem: An Interview With PharmAsia News

This article was originally published in PharmAsia News

Executive Summary

Among the first wave of returnees back to China, Samantha Du, who conducted global licensing for metabolic diseases with Pfizer, and cofounded Hutchison Chi-Med., returned to Shanghai to start biotech company Hutchison MediPharma in 2002
Advertisement
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

SC076219

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel